SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019380
Filing Date
2023-11-29
Accepted
2023-11-29 16:05:16
Documents
15
Period of Report
2023-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20231121x8k.htm   iXBRL 8-K 42513
2 EX-4.1 rsls-20231121xex4d1.htm EX-4.1 152476
3 EX-10.1 rsls-20231121xex10d1.htm EX-10.1 62576
4 EX-99.1 rsls-20231121xex99d1.htm EX-99.1 9311
  Complete submission text file 0001558370-23-019380.txt   434199

Data Files

Seq Description Document Type Size
5 EX-101.SCH rsls-20231121.xsd EX-101.SCH 3108
6 EX-101.LAB rsls-20231121_lab.xml EX-101.LAB 15243
7 EX-101.PRE rsls-20231121_pre.xml EX-101.PRE 9784
9 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20231121x8k_htm.xml XML 4720
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 231452197
SIC: 3841 Surgical & Medical Instruments & Apparatus